- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A Case of Endolymphatic Sac Tumor
-
- Masuda Risa
- University of Occupational and Environmental Health
-
- Katoh Akiko
- University of Occupational and Environmental Health
-
- Ohbuchi Toyoaki
- University of Occupational and Environmental Health
-
- Hohchi Nobusuke
- University of Occupational and Environmental Health
-
- Hashida Koichi
- University of Occupational and Environmental Health
-
- Takenaga Fumiko
- University of Occupational and Environmental Health
-
- Suzuki Hideaki
- University of Occupational and Environmental Health
Bibliographic Information
- Other Title
-
- 内リンパ囊腫瘍例
- 臨床 内リンパ囊腫瘍例
- リンショウ ナイ リンパノウ シュヨウレイ
Search this article
Description
Endolympathic sac tumor is a rare temporal bone neoplasm, and is considered to be a low-grade adenocarcinoma. Despite its slow growth and low incidence of association with distant metastasis, this tumor often shows aggressive local bone destruction. Herein, we report a rare case.<br> A 52-year-old man with Down syndrome presented with a 6-month history of hemifacial palsy. The initial examination revealed left-sided complete facial nerve palsy. Analysis of the auditory brain stem response indicated deafness on the affected side. The patient had no vertigo or nystagmus. Computed tomography revealed a well-defined osteolytic soft tissue lesion in the left petrous bone. The lesion was seen as a high intensity on both T1- and T2-weighted magnetic resonance images, and showed heterogeneous gadolinium enhancement. The labyrinth was destroyed, and the internal acoustic meatus was indistinguishable. Under a tentative diagnosis of cholesterol glanuloma, transmastoid biopsy was performed. The histopathological diagnosis was endolymphatic sac tumor. The patient eventually underwent removal of the tumor via a trans-middle cranial fossa approach following preoperative arterial embolization. His postoperative clinical course was uneventful, and he was discharged 19 days after the surgery. Although the facial nerve palsy or hearing loss did not recover, no evidence of tumor recurrence has been seen over a postoperative follow-up period of 32 months. A bibliographic review of the clinical/histopathological characteristics, diagnosis and treatement of endolymphatic sac tumor is presented.<br>
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 106 (6), 509-513, 2013
The Society of Practical Otolaryngology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679249499904
-
- NII Article ID
- 130004558685
- 10031174674
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 21851557
- 00326313
- 09121870
-
- NDL BIB ID
- 024677666
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed